Quote Professor Hagan Bayley: “We aim to integrate printed tissue-like materials with living tissues, and to print materials that themselves contain living cells. Our long-term goal is to develop a synthetic-tissue printer that a surgeon can use in the operating theatre.
In ten years’ time, the use of pieces of synthetic tissue will be commonplace. The fabrication of complex synthetic organs is a more distant prospect.”
Professor Bayley leads a group named OxSyBio, which is a spin-out from Isis Innovation, a business that was established by the world renown Oxford University in 1988 as its wholly owned technology transfer company. Professor Bayley’s statement is in regards to the announcement that OxSyBio has raised some £1,000,000 from IP Group plc, a developer of intellectual property based businesses, subject to the achievement of qualified milestones. The new company will refine and advance the 3D droplet printing technology devised by Professor Bayley’s group at the University’s Department of Chemistry.
OxSyBio will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company aims to 3D print synthetic tissues for organ repair or replacement. The group has developed a technique to 3D print synthetic tissue-like materials from thousands of tiny water droplets each coated in a thin film mimicking a living cell’s external membrane, and studding these membranes with protein pores so they act like simplified cells. … (Read more)